Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Driving support device, method, and program
Keyswitch controller
Para-xylylene based microfilm elution devices
Dynamic data filtering system and method
Crosslinked core/shell polymer particles
Grid computing accounting and statistics management system
Nutritional supplement method
  Randomly Featured Patents
Method and apparatus for generating a transform
Method of fabricating microelectromechanical system structures
Radiation detection apparatus
Electrically alterable field effect transistor amplifier configuration
System and method for multifunctional control of upper limb prosthesis via EMg signal identification
Adaptive recording method and apparatus for high-density optical recording, and control method therefor
Torque driving tool and retainer for driven member
Method for processing and transporting compressed natural gas
Confidence based weighting for color interpolation
Ultrasound diagnostic apparatus